Zota Health Care [ZOTA] vs NGL Fine-Chem [NGLFINE] Detailed Stock Comparison
Zota Health Care
NSE
Loading...
NGL Fine-Chem
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zota Health Care wins in 8 metrics, NGL Fine-Chem wins in 11 metrics, with 0 ties. NGL Fine-Chem appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zota Health Care | NGL Fine-Chem | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -61.40 | 41.59 | Zota Health Care |
| Price-to-Book Ratio | 35.51 | 3.11 | NGL Fine-Chem |
| Debt-to-Equity Ratio | 0.61 | 27.30 | Zota Health Care |
| PEG Ratio | -24.56 | 155.15 | Zota Health Care |
| EV/EBITDA | -933.01 | 25.94 | Zota Health Care |
| Profit Margin (TTM) | -20.55% | 5.54% | NGL Fine-Chem |
| Operating Margin (TTM) | -10.35% | 6.44% | NGL Fine-Chem |
| EBITDA Margin (TTM) | N/A | 6.44% | N/A |
| Return on Equity | -38.38% | 7.48% | NGL Fine-Chem |
| Return on Assets (TTM) | -12.84% | 4.87% | NGL Fine-Chem |
| Free Cash Flow (TTM) | $-959.42M | $-949.49M | NGL Fine-Chem |
| Dividend Yield | 0.11% | 0.26% | NGL Fine-Chem |
| 1-Year Return | 83.56% | -37.61% | Zota Health Care |
| Price-to-Sales Ratio (TTM) | 13.38 | 2.31 | NGL Fine-Chem |
| Enterprise Value | $34.19B | $8.90B | Zota Health Care |
| EV/Revenue Ratio | 11.67 | 2.33 | NGL Fine-Chem |
| Gross Profit Margin (TTM) | 56.43% | 50.19% | Zota Health Care |
| Revenue per Share (TTM) | $92 | $618 | NGL Fine-Chem |
| Earnings per Share (Diluted) | $-20.82 | $34.17 | NGL Fine-Chem |
| Beta (Stock Volatility) | 0.45 | 0.51 | Zota Health Care |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zota Health Care vs NGL Fine-Chem Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zota Health Care | -2.55% | -6.56% | 5.99% | 27.38% | 49.44% | 59.29% |
| NGL Fine-Chem | 2.12% | 2.95% | 10.24% | 9.52% | 32.03% | -21.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zota Health Care | 83.56% | 376.44% | 711.31% | 1,296.96% | 1,296.96% | 1,296.96% |
| NGL Fine-Chem | -37.61% | -12.62% | -24.71% | -24.71% | -24.71% | -24.71% |
Performance & Financial Health Analysis: Zota Health Care vs NGL Fine-Chem
| Metric | ZOTA | NGLFINE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹32.82B | ₹8.81B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 126,671 | 3,471 |
| 90 Day Avg. Volume | 90,885 | 3,042 |
| Last Close | ₹1,237.30 | ₹1,437.00 |
| 52 Week Range | ₹535.00 - ₹1,397.30 | ₹957.00 - ₹2,374.00 |
| % from 52W High | -11.45% | -39.47% |
| All-Time High | ₹1,397.30 (Aug 18, 2025) | ₹2,823.90 (Apr 22, 2024) |
| % from All-Time High | -11.45% | -49.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.84% | 0.15% |
| Quarterly Earnings Growth | 0.84% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | 0.06% |
| Operating Margin (TTM) | -0.10% | 0.06% |
| Return on Equity (TTM) | -0.38% | 0.07% |
| Debt to Equity (MRQ) | 0.61 | 27.30 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹35.76 | ₹457.16 |
| Cash per Share (MRQ) | N/A | ₹106.07 |
| Operating Cash Flow (TTM) | ₹-1,007,999,000 | ₹206.13M |
| Levered Free Cash Flow (TTM) | ₹-563,984,000 | ₹211.24M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | 0.26% |
| Last 12-Month Dividend | ₹1.00 | ₹3.50 |
Valuation & Enterprise Metrics Analysis: Zota Health Care vs NGL Fine-Chem
| Metric | ZOTA | NGLFINE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -61.40 | 41.59 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -24.56 | 155.15 |
| Price to Sales (TTM) | 13.38 | 2.31 |
| Price to Book (MRQ) | 35.51 | 3.11 |
| Market Capitalization | ||
| Market Capitalization | ₹32.82B | ₹8.81B |
| Enterprise Value | ₹34.19B | ₹8.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.67 | 2.33 |
| Enterprise to EBITDA | -933.01 | 25.94 |
| Risk & Other Metrics | ||
| Beta | 0.45 | 0.51 |
| Book Value per Share (MRQ) | ₹35.76 | ₹457.16 |
Financial Statements Comparison: Zota Health Care vs NGL Fine-Chem
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZOTA | NGLFINE |
|---|---|---|
| Revenue/Sales | ₹1.04B | ₹1.04B |
| Cost of Goods Sold | ₹451.33M | ₹518.92M |
| Gross Profit | ₹584.50M | ₹522.94M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-107.17M | ₹67.08M |
| EBITDA | ₹48.28M | ₹173.28M |
| Pre-Tax Income | ₹-130.85M | ₹118.40M |
| Income Tax | ₹6.93M | ₹25.99M |
| Net Income (Profit) | ₹-137.78M | ₹92.41M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZOTA | NGLFINE |
|---|---|---|
| Cash & Equivalents | ₹21.32M | ₹5.83M |
| Total Current Assets | ₹1.84B | ₹2.35B |
| Total Current Liabilities | ₹1.01B | ₹1.19B |
| Long-Term Debt | ₹1.08B | ₹253.36M |
| Total Shareholders Equity | ₹2.27B | ₹2.82B |
| Retained Earnings | N/A | ₹2.77B |
| Property, Plant & Equipment | ₹1.81B | ₹1.42B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZOTA | NGLFINE |
|---|---|---|
| Operating Cash Flow | ₹-8.57M | N/A |
| Capital Expenditures | ₹-982,011 | N/A |
| Free Cash Flow | ₹41.94M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZOTA | NGLFINE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 126,671 | 3,471 |
| Average Daily Volume (90 Day) | 90,885 | 3,042 |
| Shares Outstanding | 25.85M | 6.18M |
| Float Shares | 12.58M | 1.52M |
| % Held by Insiders | 0.00% | 0.74% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Zota Health Care vs NGL Fine-Chem
| Metric | ZOTA | NGLFINE |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹3.50 |
| Last 12-Month Dividend Yield | 0.11% | 0.26% |
| 3-Year Avg Annual Dividend | ₹1.17 | ₹2.33 |
| 3-Year Avg Dividend Yield | 0.30% | 0.10% |
| 3-Year Total Dividends | ₹3.50 | ₹7.00 |
| Ex-Dividend Date | Sep 20, 2024 | Aug 12, 2025 |